APA (7th ed.) Citation

Psilopatis, I., Damaskos, C., Garmpi, A., Sarantis, P., Koustas, E., Antoniou, E. A., . . . Garmpis, N. (2023). FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far? International Journal of Molecular Sciences, 24(3), 2685. https://doi.org/10.3390/ijms24032685

Chicago Style (17th ed.) Citation

Psilopatis, Iason, et al. "FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?" International Journal of Molecular Sciences 24, no. 3 (2023): 2685. https://doi.org/10.3390/ijms24032685.

MLA (9th ed.) Citation

Psilopatis, Iason, et al. "FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?" International Journal of Molecular Sciences, vol. 24, no. 3, 2023, p. 2685, https://doi.org/10.3390/ijms24032685.